Myocardial Infarct Size Immediately Dictates Systemic Inflammatory Response, with IL-6 Identified as Central Mediator

Ischemic heart disease and myocardial infarction (MI) are leading causes of global mortality and morbidity, often triggering a significant inflammatory response that can exacerbate myocardial injury. Current anti-inflammatory strategies are frequently non-specific or insufficient, highlighting a critical gap in targeted post-MI care. Understanding the specific mediators of this inflammation, particularly how it scales with infarct size, is crucial for developing effective therapies. Interleukin-6 (IL-6) is a well-known pro-inflammatory cytokine, and its precise role as a central mediator in relation to infarct size and its potential as a therapeutic target post-MI warrants deeper investigation.

This cohort study investigated the systemic inflammatory response in MI patients by stratifying them based on infarct size. Researchers performed serial measurements of C-reactive protein (CRP) and interleukin-6 (IL-6), alongside comprehensive targeted inflammatory proteomics using Olink's Target 96 Inflammation panel. Data was collected during hospitalization and extended up to 12 weeks post-MI. The primary objective was to evaluate the inflammatory burden and identify key mediators across these distinct infarct size strata (small, moderate, and large) to understand the immediate impact of myocardial injury.

Baseline IL-6 concentrations were progressively higher with increasing infarct size, demonstrating differential temporal trajectories across infarct size strata (P for interaction < 0.001). This critical finding was further confirmed by the proteomic analysis, which also showed a significant interaction effect (Padj for interaction = 0.009). Interestingly, patients with small infarct sizes did not exhibit significant changes in CRP or IL-6 concentrations over time. However, even in these small infarct cases, the study observed a downregulation of urokinase (uPA) and an upregulation of angiogenesis-related proteins, specifically tumor necrosis factor-related weak inducer of apoptosis (TWEAK) and hepatocyte growth factor (HGF). These specific protein modulations were consistent across all infarct sizes, including moderate and large, underscoring the universal biological significance of these processes in post-MI remodeling. Ultimately, the research clearly established that greater myocardial injury directly correlated with a higher systemic inflammatory burden.